Yujin Xu

1.0k total citations
45 papers, 535 citations indexed

About

Yujin Xu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yujin Xu has authored 45 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yujin Xu's work include Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (11 papers) and Lung Cancer Research Studies (9 papers). Yujin Xu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (11 papers) and Lung Cancer Research Studies (9 papers). Yujin Xu collaborates with scholars based in China, United States and Sweden. Yujin Xu's co-authors include Zhongxing Liao, Ming Chen, Weiye Deng, Weina Li, Cun Zhang, Qiang Hao, Ting Xu, Yingqi Zhang, Pei Yang and Xiaochang Xue and has published in prestigious journals such as Nature Communications, Scientific Reports and The Lancet Oncology.

In The Last Decade

Yujin Xu

40 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yujin Xu China	14	260	155	136	110	85	45	535
Helen B. Forrester Australia	16	203 0.8×	159 1.0×	282 2.1×	277 2.5×	95 1.1×	28	637
Joseph Sia Australia	8	191 0.7×	143 0.9×	105 0.8×	112 1.0×	44 0.5×	24	421
Kevin S. Roof United States	11	291 1.1×	209 1.3×	172 1.3×	62 0.6×	30 0.4×	27	581
Chang Shu Wang Canada	12	173 0.7×	241 1.6×	139 1.0×	47 0.4×	41 0.5×	15	565
Murali Rajaraman Canada	13	115 0.4×	206 1.3×	251 1.8×	145 1.3×	164 1.9×	28	845
Andrew O. Wahl United States	15	138 0.5×	120 0.8×	69 0.5×	154 1.4×	135 1.6×	39	545
Wenqing Wang China	15	252 1.0×	213 1.4×	205 1.5×	61 0.6×	13 0.2×	76	632
Kai Eichhorn Germany	7	151 0.6×	73 0.5×	121 0.9×	172 1.6×	21 0.2×	13	447
D. Kardamakis Greece	13	109 0.4×	155 1.0×	100 0.7×	101 0.9×	59 0.7×	26	388
Yasuo Matsumoto Japan	15	296 1.1×	114 0.7×	103 0.8×	91 0.8×	136 1.6×	70	598

Countries citing papers authored by Yujin Xu

Since Specialization

Citations

This map shows the geographic impact of Yujin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yujin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yujin Xu more than expected).

Fields of papers citing papers by Yujin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yujin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yujin Xu. The network helps show where Yujin Xu may publish in the future.

Co-authorship network of co-authors of Yujin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yujin Xu. A scholar is included among the top collaborators of Yujin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yujin Xu. Yujin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Yueyao, Liwei Xu, Youhua Jiang, et al.. (2025). Outcomes of neoadjuvant immunochemotherapy and neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma. Surgery. 183. 109383–109383.

Chen, Mengyuan, Runhua Li, Yue Kong, et al.. (2024). Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study. BMC Cancer. 24(1). 429–429.

Wang, Huaiyu, et al.. (2024). Enhancing outcomes in extensive-stage small cell lung cancer brain metastases: a retrospective study on the synergistic effects of immune checkpoint inhibitor, brain radiotherapy, and chemotherapy. Journal of Thoracic Disease. 16(9). 5539–5558.

Yu, Lin, Wenbin Shen, Jinjun Ye, et al.. (2024). Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study. Therapeutic Advances in Medical Oncology. 16. 12741828–12741828.

Wu, Qing, Mengyuan Chen, Fang Peng, et al.. (2023). A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy. Frontiers in Oncology. 13. 1118371–1118371. 3 indexed citations

Zhang, Jie, Yiwei Yang, Min Fang, et al.. (2023). A research on the improved rotational robustness for thoracic organ delineation by using joint learning of segmenting spatially‐correlated organs: A U‐net based comparison. Journal of Applied Clinical Medical Physics. 24(11). e14096–e14096. 1 indexed citations

Chen, Runzhe, Xuan Zhu, Wenqing Wang, et al.. (2023). Comparison of stereotactic body radiation therapy versus surgery for multiple primary lung cancers after prior radical resection: A multicenter retrospective study. Clinical and Translational Radiation Oncology. 40. 100601–100601. 4 indexed citations

Peng, Fang, Yujin Xu, Yong Bao, et al.. (2021). Five-year survival rate analysis: the combination of fortnightly-administration of endostar and concurrent chemoradiotherapy versus concurrent chemoradiotherapy in the treatment of inoperable locally advanced non-small cell lung cancer. Annals of Palliative Medicine. 10(7). 7560–7570. 7 indexed citations

Chen, Mengyuan, et al.. (2019). Comparison of clinical prognosis of chemo-radiotherapy and surgical treatment for patients with limited stage small cell lung cancer after matching. Zhonghua fangshe zhongliuxue zazhi. 28(11). 821–825. 1 indexed citations

10.

Wang, Jin, Yujin Xu, Xiao Hu, et al.. (2019). Comparison of the Efficacy of Stereotactic Body Radiotherapy versus Surgical Treatment for Early-Stage Non-Small Cell Lung Cancer after Propensity Score Matching. Translational Oncology. 12(8). 1032–1037. 13 indexed citations

11.

Chen, Guofu, Guoping Shan, Huarong Tang, et al.. (2019). Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI. BMC Cancer. 19(1). 583–583. 11 indexed citations

12.

Yang, Pei, Ting Xu, Daniel R. Gomez, et al.. (2018). Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 103(1). 123–131. 17 indexed citations

13.

Zhai, Yirui, Zhouguang Hui, Lujun Zhao, et al.. (2018). HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer. Radiotherapy and Oncology. 131. 27–34. 31 indexed citations

14.

Tang, Huarong, Jianjun Zhang, Xiao Hu, et al.. (2017). P1.07-024 EGFR Mutations in Small Cell Lung Cancer (SCLC): Genetic Heterogeneity and Prognostic Impact. Journal of Thoracic Oncology. 12(1). S710–S711. 4 indexed citations

15.

Hui, Zhouguang, Lujun Zhao, Yujin Xu, et al.. (2016). Continuous intravenous pumping (CIP) of recombinant human endostatin (Endostar) combined with concurrent radiochemotherapy in patients with unresectable stage III non-small-cell lung cancer: preliminary data of a prospective multicenter phaseIIclinical trial. Zhonghua fangshe zhongliuxue zazhi. 25(2). 114–119. 3 indexed citations

16.

Chen, Ming, Yujin Xu, Xiao Zheng, et al.. (2016). The efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience. Journal of Cancer Research and Therapeutics. 12(5). 82–82. 11 indexed citations

17.

Wang, Jin, et al.. (2014). Differences and radiation pneumonitis prediction of lung dosimetric parameters based on three normal lung definitions in 3DCRT treatment planning. Zhonghua fangshe zhongliuxue zazhi. 23(5). 396–400. 1 indexed citations

18.

Mu, Nan, Nannan Liu, Qiang Hao, et al.. (2014). Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine. BMB Reports. 47(7). 399–404. 3 indexed citations

19.

Hao, Qiang, Weina Li, Cun Zhang, et al.. (2012). TNFα induced FOXP3–NFκB interaction dampens the tumor suppressor role of FOXP3 in gastric cancer cells. Biochemical and Biophysical Research Communications. 430(1). 436–441. 15 indexed citations

20.

Xu, Yujin. (2006). A clinical study in undifferentiated small cell carcinoma of the esophagus. Zhongguo aizheng zazhi. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact